KV Pharma (KV-A) Announces Purchase Pact with Commerce Court for Up to $20M Shares
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
In a Form 8-K after the close Thursday, KV Pharma (NYSE: KV-A) disclosed it is in a purchase pact with Commerce Court Small Cap Value Fund for up to $20 million shares of stock.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple files $1 billion lawsuit against chip supplier Qualcomm
- HomeStreet (HMST) Announces Finalization of Settlement Agreement with SEC
- NRG Energy (NRG) Lenders Agree to Reprice its $1.9B Term Loan B
Create E-mail Alert Related CategoriesCorporate News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!